NLRP3 and atherosclerosis: In this study, we first confirmed the potent anti-atherogenic efficacy of Tan IIA using ApoE-/- mice—a well-established murine atherosclerosis model [52] and then further investigated whether and how Tan IIA inhibits oxLDL-induced NLRP3 inflammasome activation in macrophages.